Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7X0Z1
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 11 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016311 | dephosphorylation | 5 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0036211 | protein modification process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:0007165 | signal transduction | 2 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 11 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 11 |
GO:0016791 | phosphatase activity | 5 | 11 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.783 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.571 |
CLV_NRD_NRD_1 | 286 | 288 | PF00675 | 0.417 |
CLV_NRD_NRD_1 | 334 | 336 | PF00675 | 0.697 |
CLV_NRD_NRD_1 | 350 | 352 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.753 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.377 |
CLV_PCSK_KEX2_1 | 334 | 336 | PF00082 | 0.697 |
CLV_PCSK_KEX2_1 | 350 | 352 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.784 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.377 |
CLV_PCSK_PC7_1 | 204 | 210 | PF00082 | 0.377 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.616 |
DOC_CKS1_1 | 219 | 224 | PF01111 | 0.377 |
DOC_CKS1_1 | 85 | 90 | PF01111 | 0.520 |
DOC_CYCLIN_RxL_1 | 137 | 149 | PF00134 | 0.611 |
DOC_CYCLIN_RxL_1 | 26 | 35 | PF00134 | 0.497 |
DOC_CYCLIN_RxL_1 | 284 | 294 | PF00134 | 0.387 |
DOC_MAPK_gen_1 | 137 | 145 | PF00069 | 0.507 |
DOC_PP1_RVXF_1 | 27 | 34 | PF00149 | 0.497 |
DOC_USP7_MATH_1 | 171 | 175 | PF00917 | 0.580 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.714 |
DOC_USP7_MATH_1 | 338 | 342 | PF00917 | 0.632 |
DOC_WW_Pin1_4 | 218 | 223 | PF00397 | 0.489 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.437 |
DOC_WW_Pin1_4 | 305 | 310 | PF00397 | 0.310 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.790 |
DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.641 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.563 |
LIG_14-3-3_CanoR_1 | 12 | 17 | PF00244 | 0.692 |
LIG_14-3-3_CanoR_1 | 173 | 179 | PF00244 | 0.597 |
LIG_14-3-3_CanoR_1 | 209 | 219 | PF00244 | 0.320 |
LIG_14-3-3_CanoR_1 | 290 | 300 | PF00244 | 0.355 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.464 |
LIG_14-3-3_CanoR_1 | 55 | 61 | PF00244 | 0.798 |
LIG_BRCT_BRCA1_1 | 24 | 28 | PF00533 | 0.322 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.587 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.698 |
LIG_FHA_1 | 85 | 91 | PF00498 | 0.619 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.459 |
LIG_LIR_Gen_1 | 228 | 236 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 251 | 260 | PF02991 | 0.357 |
LIG_LIR_Nem_3 | 228 | 234 | PF02991 | 0.312 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 251 | 255 | PF02991 | 0.357 |
LIG_MLH1_MIPbox_1 | 24 | 28 | PF16413 | 0.322 |
LIG_Pex14_1 | 194 | 198 | PF04695 | 0.447 |
LIG_Pex14_2 | 225 | 229 | PF04695 | 0.310 |
LIG_Pex14_2 | 248 | 252 | PF04695 | 0.387 |
LIG_PTAP_UEV_1 | 60 | 65 | PF05743 | 0.693 |
LIG_REV1ctd_RIR_1 | 25 | 33 | PF16727 | 0.501 |
LIG_RPA_C_Fungi | 111 | 123 | PF08784 | 0.514 |
LIG_SH2_CRK | 231 | 235 | PF00017 | 0.324 |
LIG_SH2_SRC | 318 | 321 | PF00017 | 0.377 |
LIG_SH2_STAT5 | 284 | 287 | PF00017 | 0.310 |
LIG_SH3_3 | 220 | 226 | PF00018 | 0.310 |
LIG_SH3_3 | 58 | 64 | PF00018 | 0.805 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.524 |
LIG_TRAF2_1 | 94 | 97 | PF00917 | 0.528 |
LIG_UBA3_1 | 122 | 129 | PF00899 | 0.460 |
LIG_WRC_WIRS_1 | 175 | 180 | PF05994 | 0.588 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.677 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.322 |
MOD_CK1_1 | 308 | 314 | PF00069 | 0.377 |
MOD_CK1_1 | 35 | 41 | PF00069 | 0.386 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.740 |
MOD_CK2_1 | 115 | 121 | PF00069 | 0.500 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.669 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.720 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.614 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.425 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.477 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.378 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.451 |
MOD_GlcNHglycan | 340 | 343 | PF01048 | 0.606 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.767 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.574 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.701 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.310 |
MOD_GSK3_1 | 35 | 42 | PF00069 | 0.415 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.652 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.805 |
MOD_N-GLC_1 | 153 | 158 | PF02516 | 0.651 |
MOD_NEK2_1 | 100 | 105 | PF00069 | 0.460 |
MOD_NEK2_1 | 152 | 157 | PF00069 | 0.651 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.698 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.337 |
MOD_PIKK_1 | 70 | 76 | PF00454 | 0.726 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.739 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.500 |
MOD_Plk_1 | 22 | 28 | PF00069 | 0.335 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.417 |
MOD_ProDKin_1 | 218 | 224 | PF00069 | 0.489 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.437 |
MOD_ProDKin_1 | 305 | 311 | PF00069 | 0.310 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.792 |
MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.638 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.310 |
TRG_ER_diArg_1 | 349 | 351 | PF00400 | 0.609 |
TRG_Pf-PMV_PEXEL_1 | 335 | 340 | PF00026 | 0.599 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDK0 | Leptomonas seymouri | 44% | 100% |
A0A1X0NRN9 | Trypanosomatidae | 39% | 100% |
A0A422N807 | Trypanosoma rangeli | 39% | 100% |
A4HFZ8 | Leishmania braziliensis | 73% | 99% |
A4I317 | Leishmania infantum | 100% | 100% |
C9ZJI6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9ACT8 | Leishmania major | 93% | 100% |
E9AZC7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
V5BIV4 | Trypanosoma cruzi | 39% | 100% |